The investment will enable Ferty9 to expand its reach across India and supports the development of new technologies and medical innovations
Verlinvest, an international, family-backed evergreen investment company, announced its entry into India’s healthcare sector, with the acquisition of a controlling stake in Ferty9 Fertility Center, a premier chain of fertility clinics in the AP/Telangana region that was founded by Dr C Jyothi Budi and her partners in 2013.
The investment will enable Ferty9 to expand its reach across India and supports the development of new technologies and medical innovations, further strengthening Ferty9’s position as a leading fertility clinic chain. By investing around $50 million in the platform, Verlinvest will focus on scaling Ferty9’s footprint, offering, and positive impact nationally.
Verlinvest has partnered with Vinesh Gadhia, who will lead Ferty9 as its Chief Executive Officer and Executive Director of the Board to scale Ferty9’s reach and execute its ambition to acquire more fertility assets through this platform. Gadhia is an industry veteran in India’s fertility sector with over 30 years of experience in building commercial teams and expanding scientific partnerships.
Two senior investors from Verlinvest who led this investment, Shagun Tiwary Shah and Manvitha Janagam, will join Ferty9’s Board of Directors, adding to the ~70 per cent of employees at Ferty9 that are women.
Shagun said, “We are thrilled to partner with Ferty9 to create a trusted platform that will enhance accessibility to treatments for women and men struggling with infertility and offer greater choice and flexibility in terms of timing decisions around becoming parents.”
Manvitha added, “We are delighted to be working alongside Vinesh Gadhia, Dr Budi and Ferty9’s fantastic team to build and scale a market-leading IVF platform, which offers clinical excellence, quality service and excellent value for its patients.”
“With Verlinvest team’s passionate support, experience in brand-building, and operational expertise, we can now extend our mission across India and empower women with more choices for their reproductive health,” said Dr Budi, Medical Director, Ferty9 Fertility Centre.
Gadhia said, “As always, our commitment to delivering exceptional patient care remains unwavering. We see this moment as the first step towards our ambitious goal of making high-quality fertility treatments more accessible to all.”
Verlinvest’s acquisition of a controlling stake in Ferty9 Fertility Centre marks their first foray into the healthcare sector in India, having spent several decades investing in the healthcare sector in Europe. Verlinvest aims to leverage its expertise in backing market-leading consumer-focussed brands and apply it to the healthcare industry.
